Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

COAG

Hemab Therapeutics Holdings Inc

May 05 • 04:00PM ET

25.00

-0.34 -1.34 %

Healthcare • Biotechnology • USA • Nano • NASD

May 04, 4:35 PMHemab Therapeutics closes upsized IPO, including full underwriters’ option exercise, raising approximately $346.7 million in gross proceeds

Held by: TMSL

Index	-	P/E	-	EPS (ttm)	-	Insider Own	-	Shs Outstand	2.01M	Perf Week	-
Market Cap	44.50M	Forward P/E	-	EPS next Y	-	Insider Trans	-	Shs Float	-	Perf Month	-
Enterprise Value	-	PEG	-	EPS next Q	-	Inst Own	-	Short Float	-	Perf Quarter	-
Income	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	-	Perf Half Y	-
Sales	-	P/B	-	EPS next Y	-	ROA	-	Short Interest	-	Perf YTD	-26.47%
Book/sh	-	P/C	-	EPS next 5Y	-	ROE	-	52W High	36.61 -31.71%	Perf Year	-
Cash/sh	-	P/FCF	-	EPS past 3/5Y	- -	ROIC	-	52W Low	24.94 0.24%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	- -	Perf 5Y	-
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-	Oper. Margin	-	ATR (14)	6.79	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	-	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	-	Recom	-
Dividend Gr. 3/5Y	- -	Current Ratio	-	EPS Q/Q	-	SMA20	-11.07%	Beta	-	Target Price	-
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-11.07%	Rel Volume	0.20	Prev Close	25.34
Employees	72	LT Debt/Eq	-	Earnings	-	SMA200	-11.07%	Avg Volume	2.35M	Price	25.00
IPO	May 01, 2026	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	461,164	Change	-1.34%

May-04-26 04:01PM

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

(GlobeNewswire) -25.47%

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded on February 12, 2026 and is headquartered in Cambridge, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

COAG

Hemab Therapeutics Holdings Inc

Upgrade your Finviz experience